Former Vodaphone head to lead ABPI comms
November 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aileen Thompson, meadon, vodaphone
The ABPI has appointed a new director of communications in Aileen Thompson, a former Vodaphone head who replaces Catherine Meadon in …
Wales Assembly facing questions over cancer
November 5, 2014Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology
The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …
Retrospective study backs Iressa use in oesophageal cancer
November 5, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Cancer Oesophagus Gefitinib, Iressa, gefitinib, oncology
A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …
LabCorp buys Covance for $6.1 billion
November 5, 2014Research and Development, Sales and Marketing CRO, Covance, king, labcorp, medical
US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …
Horizon Discovery names executive director
November 5, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Horizon Discovery, david smoller
Cambridge-based genetics research firm Horizon Discovery has appointed Dr David Smoller to be an executive director on its board. Smoller …
AstraZeneca buys biotech Definiens
November 4, 2014Research and Development, Sales and Marketing AstraZeneca, Janssen, MedImmune, Pharmacyclics, binnig, definiens
AstraZeneca has strengthened its oncology capabilities with the acquisition of Definiens, a German company that has pioneered cancer imaging and …
Astellas teams up with Proteostasis against protein defects
November 4, 2014Research and Development, Sales and Marketing Astellas, Biogen IDEC, Protein, Proteostasis, upr
Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …
Sir Michael Rawlins appointed chair of MHRA
November 4, 2014Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, NHS, NICE, gordon duff, michael rawlins
The Medicines and Healthcare Products Regulatory Agency (MHRA) has confirmed that former NICE head Sir Michael Rawlins is to serve …
NICE backs GSK’s leukaemia drug Arzerra following price cut
November 4, 2014Sales and Marketing Arzerra, CLL, GSK, NHS, NICE, leukaemia
NICE has recommended that GlaxoSmithKline’s Arzerra be prescribed under the NHS for patients with chronic lymphocytic leukaemia (CLL), after a …
EMA review for Biogen Idec’s haemophilia A therapy
November 4, 2014Sales and Marketing Biogen, elocta, eloctate, haemophilia a, idec, sobi
The EMA is set to review Biogen Idec and Sobi’s haemophilia A therapy Elocta after validating the drug’s marketing authorisation …
Alnylam poaches VP from Bristol-Myers Squibb
November 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alnylam, pushkal garg
US-based RNAi therapeutics firm Alnylam Pharmaceuticals has appointed Dr Pushkal Garg to the position of senior vice president of its …
AstraZeneca completes respiratory deal with Almirall
November 3, 2014Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory
AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …
Novo Nordisk to open $130 million diabetes labs
November 3, 2014Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes
Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …
UK doctors are ignoring statin guidance
November 3, 2014Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins
A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …
Reprieve for Boehringer plant as Chinese buyer comes forward
November 3, 2014Manufacturing and Production Boehringer, China, Petersburg, UniTao Pharmaceuticals
A US manufacturing facility cued up for closure by Boehringer Ingelheim has been bought by a Chinese drugmaker. Boehringer had …
Growing IPF drugs market evident at ERS Congress
November 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ERS, Esbriet, IPF, elf, european respiratory society, ofev
Arriving in Germany for this year’s European Respiratory Society (ERS) International Congress 2014, what awaited Pharmafile at the Ausgang was …
Takeda hires Merck senior head as president
November 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, marc princen
Marc Princen has joined Takeda Pharmaceuticals from Merck and is to serve as its corporate officer and president of the …
AbbVie financials beat expectations
October 31, 2014Sales and Marketing AbbVie, Abbott, Creon, Humira, Iopinavir/ritonavir, Kaletra, Q3, Synthroid, levothyroxine, pancrelipase
AbbVie has announced higher-than-expected financial results for the third quarter of 2014, although it continues to rely heavily on blockbuster …
BMS and Lonza announce expansion plans
October 31, 2014Manufacturing and Production, Sales and Marketing BMS, Lonza, Orencia, manufacturing, opdivo
Bristol-Myers Squibb (BMS) and Lonza are to expand upon an existing manufacturing agreement to meet anticipated demand for commercial biologics. …
NICE recommends new indication for troubled Pradaxa
October 31, 2014Sales and Marketing Boehringer, NHS, NICE, Pradaxa, dabigatran, ingelheim, warfarin
NICE has recommended Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa for treating and preventing potentially-fatal blood clots in the legs …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
